Interact to see
Advertisement
Advertisement
HBLTX vs MROSX
HBLTX vs MROSX Comparison
Open Charts HBLTX vs MROSX
Hartford Balanced Income R5
Price$14.72
Change-$0.08 (-0.54%)
VolumeN/A
Net Assets11.79B
MassMutual 40/60 Allocation R5
Price$9.07
Change-$0.06 (-0.66%)
VolumeN/A
Net Assets181.78M
HBLTX vs MROSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
HBLTX vs. MROSX commentary
Jun 17, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLTX is a Buy and MROSX is a Hold.
FUNDAMENTALS
Fundamentals
HBLTX has more cash in the bank: 11.8B vs. MROSX (182M). HBLTX pays higher dividends than MROSX: HBLTX (3.56) vs MROSX (3.26). HBLTX was incepted earlier than MROSX: HBLTX (15 years) vs MROSX (14 years). MROSX (0.69) and HBLTX (0.66) have similar cost to investors . HBLTX (0) and MROSX (0) have matching initial minimum investment requirements. MROSX annual gain was more profitable for investors over the last year : 5.99 vs. HBLTX (4.71). HBLTX return over 5 years is better than : 17.41 vs. MROSX (12.81).
| HBLTX | MROSX | HBLTX / MROSX | |
| Total Expense Ratio | 0.66 | 0.69 | 96% |
| Annual Report Gross Expense Ratio | 0.66 | 0.69 | 96% |
| Fund Existence | 15 years | 14 years | - |
| Gain YTD | 4.039 | 3.657 | 110% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 11.8B | 182M | 6,484% |
| Annual Yield % from dividends | 3.56 | 3.26 | 109% |
| Returns for 1 year | 4.71 | 5.99 | 79% |
| Returns for 3 years | 16.62 | 16.76 | 99% |
| Returns for 5 years | 17.41 | 12.81 | 136% |
| Returns for 10 years | 39.57 | 19.00 | 208% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AZNAX | 11.06 | -0.07 | -0.63% |
| Virtus Income & Growth A | |||
| FBTCX | 20.46 | -0.13 | -0.63% |
| Fidelity Advisor Biotechnology C | |||
| MSCUX | 11.89 | -0.15 | -1.25% |
| Morgan Stanley American Resilience A | |||
| NGRRX | 33.08 | -0.43 | -1.28% |
| Nuveen International Value I | |||
| MNHCX | 25.58 | -0.40 | -1.54% |
| Manning & Napier Pro-Blend Max Term L | |||